Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cole

Showing results (781-790 of 805) with videos related to

Pageof 81
Sort By:
Nature Communications|February 23, 2021
Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1Jang-June Park, Emily P Thi, Victor H Carpio, et al.
Science (New York, N.Y.)|August 7, 1998
DARPP-32: regulator of the efficacy of dopaminergic neurotransmissionA A Fienberg, N Hiroi, P G Mermelstein, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Sulfonamido-aryl ethers as bradykinin B1 receptor antagonistsAndrew G Cole, Axel Metzger, Marc-Raleigh Brescia, et al.
ACS Infectious Diseases|April 23, 2024
Discovery of <i>C</i>-Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV-2Eugen F Mesaros, Benjamin J Dugan, Min Gao, et al.
Nature|February 18, 2016
The mid-developmental transition and the evolution of animal body plansMichal Levin, Leon Anavy, Alison G Cole, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitorsAndrew G Cole, Adolph C Bohnstedt, Vidyadhar Paradkar, et al.
Nature|November 2, 2019
Author Correction: The mid-developmental transition and the evolution of animal body plansMichal Levin, Leon Anavy, Alison G Cole, et al.
JAMA Psychiatry|September 8, 2016
Association Between Chronic Physical Conditions and the Effectiveness of Collaborative Care for Depression: An Individual Participant Data Meta-analysisMaria Panagioti, Peter Bower, Evangelos Kontopantelis, et al.
Nucleic Acids Research|October 30, 2018
COSMIC: the Catalogue Of Somatic Mutations In CancerJohn G Tate, Sally Bamford, Harry C Jubb, et al.
Antiviral Research|November 26, 2021
Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core proteinNagraj Mani, Andrew G Cole, Janet R Phelps, et al.
Pageof 81

Showing results (781-790 of 805) with videos related to

Sort By:
Pageof 81
Nature Communications|February 23, 2021
Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1Jang-June Park, Emily P Thi, Victor H Carpio, et al.
Science (New York, N.Y.)|August 7, 1998
DARPP-32: regulator of the efficacy of dopaminergic neurotransmissionA A Fienberg, N Hiroi, P G Mermelstein, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Sulfonamido-aryl ethers as bradykinin B1 receptor antagonistsAndrew G Cole, Axel Metzger, Marc-Raleigh Brescia, et al.
ACS Infectious Diseases|April 23, 2024
Discovery of <i>C</i>-Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV-2Eugen F Mesaros, Benjamin J Dugan, Min Gao, et al.
Nature|February 18, 2016
The mid-developmental transition and the evolution of animal body plansMichal Levin, Leon Anavy, Alison G Cole, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitorsAndrew G Cole, Adolph C Bohnstedt, Vidyadhar Paradkar, et al.
Nature|November 2, 2019
Author Correction: The mid-developmental transition and the evolution of animal body plansMichal Levin, Leon Anavy, Alison G Cole, et al.
JAMA Psychiatry|September 8, 2016
Association Between Chronic Physical Conditions and the Effectiveness of Collaborative Care for Depression: An Individual Participant Data Meta-analysisMaria Panagioti, Peter Bower, Evangelos Kontopantelis, et al.
Nucleic Acids Research|October 30, 2018
COSMIC: the Catalogue Of Somatic Mutations In CancerJohn G Tate, Sally Bamford, Harry C Jubb, et al.
Antiviral Research|November 26, 2021
Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core proteinNagraj Mani, Andrew G Cole, Janet R Phelps, et al.
Pageof 81